This past spring, Governor Andrew Cuomo, Empire State Development and Roswell
Park Cancer Institute
announced an agreement between Roswell Park Cancer Institute and the Cuban Center for Molecular
Immunology. According to Roswell Park CEO and president, Dr. Johnson,
Cuba has developed a vaccine for slowing the growth of lung cancer. The
vaccine, known as CIMAvax-EGF vaccine, was developed to help treat lung
cancer in Cuba, where lung cancer is one of the leading causes of death.
For someone in the early stages of the disease, for instance a patient
with recent surgery to remove a nodule, the vaccine might make all the
Due to the new agreement, the vaccine, which is already in use in Cuba,
will be the subject of an early phase clinical trial at Roswell Park.
Lung cancer patients face a very high risk of reoccurrence and the vaccine
is aimed at slowing future nodule growth by targeting a specific hormone
which encourages tumors to grow. The vaccine works by creating a protein
in the body that primes the immune system to attack a hormone called
epidermal growth factor (EGF). The growth factor is the drive behind recurring cancers. If this
is taken away, as the vaccine aims to do, then the cancer will have a
much more difficult time recurring.
Roswell Park already
has several cancer vaccines in clinical trials in conjunction with their
Center for Immunotherapy, including NYESO-1 for ovarian cancer and acute myeloid leukemia, HSP
for melanoma and SurVaxM for glioma and multiple myeloma. The doctors
and researchers at Roswell are hoping that the partnership with Cuba is
another milestone in the new era of cancer vaccine research.
Railroad workers who have been exposed to asbestos or diesel exhaust are
at an increased risk of lung cancer. If you or a loved one are a current
or former railroad worker diagnosed with cancer, pleasecontact us to discuss your legal rights with an experienced railroad injury lawyer.